I

Immatics NV
D

IMTX

8.97000
USD
-0.19
(-2.06%)
مفتوح الان
حجم التداول
564
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
1,237,044,292
أصول ذات صلة المقالات
المزيد

العنوان: Immatics NV

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.